The development and validation of a novel outcome measure to quantify mobility in the dysvascular lower extremity amputee: the amputee single item mobility measure

被引:12
|
作者
Norvell, Daniel C. [1 ]
Williams, Rhonda M. [2 ,3 ]
Turner, Aaron P. [2 ,3 ]
Czerniecki, Joseph M. [2 ,3 ]
机构
[1] Spectrum Res Inc, 705 S 9th St,Suite 203, Tacoma, WA 98407 USA
[2] VA Puget Sound Hlth Care Syst, Seattle, WA USA
[3] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA
关键词
Amputation; diabetes; peripheral arterial disease; patient-reported outcome; mobility; validity; QUALITY-OF-LIFE; LOWER-LIMB AMPUTATION; HEALTH-STATUS; PROSTHETIC PROFILE; PEOPLE; QUESTIONNAIRE; VALIDITY; VERSION; SCALES; INDEX;
D O I
10.1177/0269215516644308
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: This study describes the development and psychometric evaluation of a novel patient-reported single-item mobility measure. Design: Prospective cohort study. Setting: Four Veteran's Administration Medical Centers. Subjects: Individuals undergoing their first major unilateral lower extremity amputation; 198 met inclusion criteria; of these, 113 (57%) enrolled. Interventions: None. Main measures: The Amputee Single Item Mobility Measure, a single item measure with scores ranging from 0 to 6, was developed by an expert panel, and concurrently administered with the Locomotor Capabilities Index-5 (LCI-5) and other outcome measures at six weeks, four months, and 12 months post-amputation. Criterion and construct validity, responsiveness, and floor/ceiling effects were evaluated. Responsiveness was assessed using the standardized response mean. Results: The overall mean 12-month Amputee Single Item Mobility Measure score was 3.391.4. Scores for transmetatarsal, transtibial, and transfemoral amputees were 4.2 (+/- 1.3), 3.2 (+/- 1.5), and 2.9 (+/- 1.1), respectively. Amputee Single Item Mobility Measure scores demonstrated large and statistically significant correlations with the LCI-5 scores at six weeks (r=0.72), four months (r=0.81), and 12 months (r=0.86). At four months and 12months, the correlation between Amputee Single Item Mobility Measure scores and hours of prosthetic use were r=0.69 and r=0.66, respectively, and between Amputee Single Item Mobility Measure scores and Trinity Amputation and Prosthesis Experience Scales functional restriction scores were r=0.45 and r=0.67, respectively. Amputee Single Item Mobility Measure scores increased significantly from six weeks to 12months post-amputation. Minimal floor/ceiling effects were demonstrated. Conclusions: In the unilateral dysvascular amputee, the Amputee Single Item Mobility Measure has strong criterion and construct validity, excellent responsiveness, and does not exhibit floor/ceiling effects.
引用
收藏
页码:878 / 889
页数:12
相关论文
共 45 条
  • [41] The inclusion body myositis-health index (IBM-HI): Development and validation of a novel, disease-specific, patient-reported outcome measure
    Rosero, Spencer
    Seabury, Jamison
    Bhagchandani, Perya
    Weinstein, Jennifer
    Varma, Anika
    Zizzi, Christine
    Heatwole, John
    Khosa, Shaweta
    Engebrecht, Charlotte
    Johnson, Nicholas
    Gibson, Cynthia
    Dilek, Nuran
    Marten, Bill
    Heatwole, Chad
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [42] The Crohn's Disease-Health Index (CD-HI): Development and Validation of a Novel, Disease-Specific Patient Reported Outcome Measure for Clinical Trials
    Jamison, Seabury
    Jennifer, Weinstein
    Spencer, Rosero
    Anika, Varma
    Ellen, Wagner
    Christine, Zizzi
    Nuran, Dilek
    Michael, McDermott
    Aaron, Kaat
    Lawrence, Saubermann
    Larissa, Temple
    Scott, Rogoff
    Chad, Heatwole
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S12 - S12
  • [43] Development and validation of a novel personalized electronic patient-reported outcome measure to assess quality of life (Q-LIFE): a prospective observational study in people with Cystic Fibrosis
    Muilwijk, Danya
    van Paridon, Tessa J.
    van der Heijden, Doris C.
    Faber-Bisschop, Brenda M.
    Zomer-van Ommen, Domenique D.
    Heijerman, Harry G. M.
    van der Ent, Cornelis K.
    ECLINICALMEDICINE, 2023, 62
  • [44] Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials
    Jha, Manish K.
    South, Charles
    Trivedi, Jay
    Minhajuddin, Abu
    Rush, A. John
    Trivedi, Madhukar H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2019, 22 (05): : 339 - 348
  • [45] P047 The Crohn's Disease-Health Index (CD-HI): Development and Validation of a Novel, Disease-Specific Patient-Reported Outcome Measure for Clinical Trials (vol 116, pg S12, 2021)
    Seabury, Jamison
    Weinstein, Jennifer
    Rosero, Spencer
    Varma, Anika
    Wagner, Ellen
    Zizzi, Christine
    Dilek, Nuran
    McDermott, Michael
    Kaat, Aaron
    Saubermann, Lawrence
    Temple, Larissa
    Rogoff, Scott
    Heatwole, Chad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (05): : 817 - 817